# Butterfly Network, Inc.: overview

BFLY · NYSE · CIK 1804176 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bfly.md) · [Financials](/companies/bfly/financials.md) · [Filings](/companies/bfly/filings.md) · [Insiders](/companies/bfly/insiders.md)

Latest reported revenue: [$32.6m](/filings/0001804176-26-000040.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001804176-26-000040).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [22.4 d](/filings/0001804176-26-000009.md) | [21.2](/filings/0001804176-26-000016.md) | [23.4](/filings/0001804176-26-000027.md) | [21.5](/filings/0001804176-26-000040.md) | [31.5 d](/filings/0001804176-26-000009.md) | [26.5](/filings/0001804176-26-000016.md) | [32.6](/filings/0001804176-26-000027.md) | [32.6](/filings/0001804176-26-000040.md) |
| Gross margin | % | [61.5% d](/filings/0001804176-26-000009.md) | [63.0%](/filings/0001804176-26-000016.md) | [63.7%](/filings/0001804176-26-000027.md) | [(17.5%)](/filings/0001804176-26-000040.md) | [67.3% d](/filings/0001804176-26-000009.md) | [68.9%](/filings/0001804176-26-000016.md) | [71.4%](/filings/0001804176-26-000027.md) | [73.0%](/filings/0001804176-26-000040.md) |
| Operating margin | % | [(77.5%) d](/filings/0001804176-26-000009.md) | [(87.0%)](/filings/0001804176-26-000016.md) | [(68.9%)](/filings/0001804176-26-000027.md) | [(163.5%)](/filings/0001804176-26-000040.md) | [(53.0%) d](/filings/0001804176-26-000009.md) | [(52.3%)](/filings/0001804176-26-000016.md) | [(41.9%)](/filings/0001804176-26-000027.md) | [(41.7%)](/filings/0001804176-26-000040.md) |
| Net margin | % | [(81.0%) d](/filings/0001804176-26-000009.md) | [(65.8%)](/filings/0001804176-26-000016.md) | [(59.2%)](/filings/0001804176-26-000027.md) | [(158.1%)](/filings/0001804176-26-000040.md) | [(48.5%) d](/filings/0001804176-26-000009.md) | [(47.8%)](/filings/0001804176-26-000016.md) | [(39.6%)](/filings/0001804176-26-000027.md) | [(39.3%)](/filings/0001804176-26-000040.md) |
| Diluted EPS | $ per share | not reported | [(0.06)](/filings/0001804176-26-000016.md) | [(0.06)](/filings/0001804176-26-000027.md) | [(0.13)](/filings/0001804176-26-000040.md) | not reported | [(0.05)](/filings/0001804176-26-000016.md) | [(0.05)](/filings/0001804176-26-000027.md) | [(0.05)](/filings/0001804176-26-000040.md) |
| Free cash flow | $m | [(3.5) d](/filings/0001804176-26-000009.md) | [(12.0)](/filings/0001804176-26-000016.md) | [(8.1) d](/filings/0001804176-26-000027.md) | [(3.9) d](/filings/0001804176-26-000040.md) | [7.9 d](/filings/0001804176-26-000009.md) | [(14.8)](/filings/0001804176-26-000016.md) | [(17.2) d](/filings/0001804176-26-000027.md) | [(3.4) d](/filings/0001804176-26-000040.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [62.6](/filings/0001558370-24-002308.md) | [73.4](/filings/0001628280-25-009036.md) | [65.9](/filings/0001804176-26-000009.md) | [82.1](/filings/0001804176-26-000009.md) | [97.6](/filings/0001804176-26-000009.md) |
| Gross margin | % | [27.3%](/filings/0001558370-24-002308.md) | [53.8%](/filings/0001628280-25-009036.md) | [25.6%](/filings/0001804176-26-000009.md) | [59.5%](/filings/0001804176-26-000009.md) | [46.9%](/filings/0001804176-26-000009.md) |
| Operating margin | % | [(308.0%)](/filings/0001558370-24-002308.md) | [(263.0%)](/filings/0001628280-25-009036.md) | [(221.0%)](/filings/0001804176-26-000009.md) | [(90.7%)](/filings/0001804176-26-000009.md) | [(88.5%)](/filings/0001804176-26-000009.md) |
| Net margin | % | [(51.8%)](/filings/0001558370-24-002308.md) | [(229.9%)](/filings/0001628280-25-009036.md) | [(202.9%)](/filings/0001804176-26-000009.md) | [(88.3%)](/filings/0001804176-26-000009.md) | [(79.0%)](/filings/0001804176-26-000009.md) |
| Diluted EPS | $ per share | [(0.19)](/filings/0001558370-24-002308.md) | [(0.84)](/filings/0001628280-25-009036.md) | [(0.65)](/filings/0001804176-26-000009.md) | [(0.34)](/filings/0001804176-26-000009.md) | [(0.31)](/filings/0001804176-26-000009.md) |
| Free cash flow | $m | [(197)](/filings/0001558370-24-002308.md) | [(187)](/filings/0001628280-25-009036.md) | [(105)](/filings/0001804176-26-000009.md) | [(44.4)](/filings/0001804176-26-000009.md) | [(16.0)](/filings/0001804176-26-000009.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bfly/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $158.5m | 18,821,463 |  | Added +2,859,983 |
| [GLENVIEW CAPITAL MANAGEMENT, LLC](/funds/1138995.md) | 2026-06-30 | $120.7m | 14,335,055 |  | Unchanged |
| [Hood River Capital Management LLC](/funds/1578177.md) | 2026-06-30 | $111.1m | 13,190,130 |  | Added +4,569,282 |
| [Fosun International Ltd](/funds/1447884.md) | 2026-06-30 | $86.2m | 10,234,923 |  | Reduced −481,707 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $72.1m | 8,559,346 |  | Added +367,227 |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $53.8m | 6,392,827 |  | Added +5,272,536 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $48.5m | 5,762,672 |  | Added +223,012 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $45.0m | 5,345,672 |  | Added +536,568 |
| [ARK Investment Management LLC](/funds/1697748.md) | 2026-06-30 | $42.8m | 5,085,456 |  | Reduced −142,047 |
| [Nuveen, LLC](/funds/1871926.md) | 2026-06-30 | $42.6m | 5,056,372 |  | Added +1,306,436 |

## Recent filings

[All 651 filings](/companies/bfly/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 06:40 ET | [10-Q](/filings/0001804176-26-000040.md) | Quarterly report, period 2026-09-30 | 0001804176-26-000040 |
| 2026-10-29 | 06:33 ET | [8-K](/filings/0001804176-26-000038.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804176-26-000038 |
| 2026-10-05 | 08:03 ET | [8-K](/filings/0001804176-26-000033.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001804176-26-000033 |
| 2026-08-17 | 19:02 ET | [SCHEDULE 13D/A](/filings/0000905148-26-003785.md) | Ownership report, active investor, amended | 0000905148-26-003785 |
| 2026-08-17 | 18:30 ET | [SCHEDULE 13D/A](/filings/0001104659-26-097972.md) | Ownership report, active investor, amended | 0001104659-26-097972 |
| 2026-08-11 | 08:09 ET | [8-K](/filings/0001804176-26-000030.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001804176-26-000030 |
| 2026-07-30 | 07:31 ET | [10-Q](/filings/0001804176-26-000027.md) | Quarterly report, period 2026-06-30 | 0001804176-26-000027 |
| 2026-07-30 | 06:32 ET | [8-K](/filings/0001804176-26-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804176-26-000025 |
| 2026-07-21 | 19:58 ET | [SCHEDULE 13D/A](/filings/0001104659-26-085499.md) | Ownership report, active investor, amended | 0001104659-26-085499 |
| 2026-07-17 | 16:20 ET | [SCHEDULE 13D/A](/filings/0001104659-26-084641.md) | Ownership report, active investor, amended | 0001104659-26-084641 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001804176-26-000009.md), filed Feb 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/818d16f9-41f4-451b-baa9-2f5722aa13a6)

## About the filer

- CIK: 1804176
- Tickers: BFLY
- Exchange: NYSE
- SIC code: 3844 X-Ray Apparatus & Tubes & Related Irradiation Apparatus
- State of incorporation: DE
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 07:34 ET. No prices; not investment advice.
